September 30, 2025 — Gilead’s Epclusa (sofosbuvir/velpatasvir, 400mg/100mg) continues to reshape hepatitis C management worldwide. As the first and only all-oral, pan-genotypi...
When undergoing targeted cancer therapy, diet often becomes a concern for many patients. The truth is, there’s no need for overly strict restrictions, but maintaining a light, bal...